GRAS Notices

GRN No. 807

Intended Use:	For use as an ingredient in baby, infant, and toddler foods (excluding infant formula); baked goods and baking mixes; beverage and beverage bases; breakfast cereals; cheeses; chewing gum; dairy product analogs; frozen dairy desserts and mixes; gelatins, puddings, and fillings; grain products and pastas; hard candy; milk, whole and skim; milk products; nuts and nut products; processed fruits and fruit juices; soft candy; sweet sauces, toppings, and syrups at a level of 20 mg per serving, providing a minimum of 1x10⁹ CFU/serving.
Basis:	Scientific procedures
Notifier:	BLIS Technologies Ltd.
Notifier Address:	81 Glasgow Street South Dunedin, Dunedin 9012 New Zealand
GRAS Notice (releasable information):	GRN 807 (in PDF) (2.4 MB)
Date of closure:	Apr 18, 2019
Date of FDA’s corrected letter:	Jun 6, 2019
FDA's Letter:	FDA has no questions (in PDF) (62 kB)